According to the International Foundation for Gastrointestinal Disorders, IBS affects nearly 45 million people in the U.S. and 10% to 15% of the global population. Although common, many people remain undiagnosed and unaware that their symptoms can be managed. Further, patients are often stigmatized and misunderstood, creating a significant impact on their quality of life.
While the exact pathogenesis of IBS remains largely unknown, scientific evidence points to disturbances in gut, brain and nervous system interaction that can cause changes to normal bowel function and produce symptoms ranging from mild inconvenience to severe debilitation.
“Though strategies for managing IBS have evolved, one guiding principle remains true: There is no one-size-fits-all treatment strategy. IBS care in 2022 and beyond no longer relies on just the GI doctor but is a ‘team sport’ that involves a multidisciplinary, integrative care team of dietitians, behavioral therapists and maybe even complimentary alternative medicine providers,” Chey said during his J. Edward Berk Distinguished Lecture at the American College of Gastroenterology Annual Scientific Meeting 2021.
Please see your Gastroenterologist if you have any questions or think you may have IBS or other gastric issues.